The Simple Reason Why I Won't Buy MannKind Corporation Stock [The Motley Fool]
MannKind Corporation (MNKD)
Last mannkind corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.mannkindcorp.com/press-releases
Company Research
Source: The Motley Fool
MannKind isn't a turnaround story worth buying. George Budwell ( TMFGBudwell ) Jan 18, 2018 at 10:00AM Buying biotech stocks that have fallen on hard times can be a great way to generate outstanding returns on capital. Brave investors who bought Acadia Pharmaceuticals and Exelixis after their respective clinical setbacks, after all, have profited handsomely ever since. That being said, the stark reality is that most beaten-down biotechs actually deserve their rock-bottom valuations, and are therefore best avoided. MannKind Corporation ( NASDAQ:MNKD ) , for example, has now fallen by over 92% from its former highs following the Food and Drug Administration approval of its inhaled insulin product, Afrezza, on June 27, 2014. Despite the fact that Afrezza is one of the fastest-acting insulins on the market, and the diabetes drug market is massive, I
Show less
Read more
Impact Snapshot
Event Time:
MNKD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNKD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNKD alerts
High impacting MannKind Corporation news events
Weekly update
A roundup of the hottest topics
MNKD
News
- MannKind Repays Certain Debt Obligations [Yahoo! Finance]Yahoo! Finance
- MannKind Repays Certain Debt ObligationsGlobeNewswire
- MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns [Yahoo! Finance]Yahoo! Finance
- MannKind Announces CFO Transition [Yahoo! Finance]Yahoo! Finance
- MannKind CFO Steven Binder to retire [Seeking Alpha]Seeking Alpha
MNKD
Earnings
- 2/27/24 - Beat
MNKD
Sec Filings
- 4/22/24 - Form 3
- 4/5/24 - Form ARS
- 4/5/24 - Form DEFA14A
- MNKD's page on the SEC website